1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Baseline characteristics of the control (healthy volunteers) and patient groups
Healthy volunteers (n = 14)
    Age, years (± SD)26 ± 5
    Male sex (n [%])7 (50%)
Patient population (n = 57)
    Age, years (± SD)44 ± 16
    Male sex (n [%])32 (56%)
Tumor localization (n [%])
    Affecting Broca area19 (33%)
    Affecting Wernicke area38 (67%)
WHO tumor grade (n [%])
    I9 (16%)
    II12 (21%)
    III4 (4%)
    IV12 (21%)
    No WHO grade16 (28%)
    No histology available4 (7%)
  • Note:—For tumor data, n = 57.